Pharmacokinetics of gabapentin in paediatric patients with uncontrolled seizures

Journal of Clinical Pharmacy and Therapeutics

Volumn 29, Issue 6, 2004, Pages 511-515

  Tallian, K B ^a   Nahata, Milap C ^b   Lo, W ^b   Tsao, C Y ^b  

^a RADY CHILDREN'S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Epilepsy; Gabapentin; Neurontin; Paediatric; Pharmacokinetics

Indexed keywords

ACETAZOLAMIDE; CARBAMAZEPINE; CLORAZEPATE; ETHOSUXIMIDE; GABAPENTIN; LAMOTRIGINE; MESUXIMIDE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ADOLESCENT; AGGRESSION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG TOLERABILITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MULTIVARIATE ANALYSIS; REVIEW; SEIZURE; SIDE EFFECT; TREATMENT OUTCOME; WEIGHT GAIN;

ADOLESCENT; AMINES; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; CYCLOHEXANECARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EPILEPSY, PARTIAL, SENSORY; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MULTIVARIATE ANALYSIS; TIME FACTORS;

EID: 10844270314     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2004.00596.x     Document Type: Review

References (20)

1. UK Gabapentin Study group (1990) Gabapentin in partial epilepsy. Lancet, 335, 1114-1117.
2. US Gabapentin Study Group No. 5 (1993) Gabapentin as add-on therapy in refractory. Neurology, 43, 2292-2298.
3. US Gabapentin Study Group (1994) The long-term safety and efficacy of gabapentin (Neurontin®) as add-on therapy in drug-resistant partial epilepsy. Epilepsy Res, 18, 67-73.
4. Bergey GK, Morris HH, Rosenfeld W et al. (1997) Gabapentin monotherapy: an 8-day, double-blind, dose-controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures. Neurology, 49, 739-745.
5. Beydoun A, Fischer J, Labar DR et al. (1997) Gabapentin monotherapy: a 26-week, double-blind, dose controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. Neurology, 49, 746-752.
6. Appleton R, Fichtner K, LaMoreaux L et al. (1999) Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week multicenter, double-blind, placebo-controlled study. Epilepsia, 40, 1147-1154.
7. Shapiro DY, Nordli D, Glauser TA et al. (2000) Gabapentin as add-on therapy for refractory partial seizures in children 1-36 months of age: a novel, short-term, placebo-controlled trial. Epilepsia, 41(Suppl. 7), 106.
8. Stewart BH, Kagler AR, Thompson PR, Bockbrader HN (1993) A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of lack of proportionally between increasing dose and drug levels in plasma. Pharmacol Res, 10, 276-281.
9. Taylor CP (1995) Gabapentin: mechanisms of action. In: Levy RH, Mattson RH, Melodrum BS, eds. Antiepileptic drugs, 4th edn. New York: Raven Press, 829-841.
10. McLean MJ (1999) Gabapentin in the management of convulsive disorders. Epilepsia, 40(Suppl. 6), S39-S50.
11. Anonymous (1993) Gabapentin. Product Information. Morris Plains, NJ: Parke-Davis, Division of Warner-Lambert Company.
12. Haig GM, Bockbrader HN, Wesch DL et al. (2001) Single-dose gabapentin pharmacokinetics and safety in healthy infants and children. J Clin Pharmacol, 41, 507-514.
13. Ouellet D, Bockbrader HN, Wesche DL, Shapiro DY, Garofalo E (2001) Population pharmacokinetics of gabapentin in infants and children. Epilepsy Research, 47, 229-241.
14. Hengy H, Kolle EU (1985) Determination of gabapentin in plasma and urine by high-performance liquid chromatography and pre-column labeling for ultraviolet detection. J Chromatogr, 341, 473-478.
15. Tallian KB, Nahata MC, Lo W, Tsao CY (1996) Gabapentin associated with aggressive behavior in pediatric patients with seizures. Epilepsia, 37, 501-502.
16. Richens A. (1993) Clinical pharmacokinetics of gabapentin. In: Chadwick D, ed. New trends in epilepsy management: the role of gabapentin. London: Royal Society of Medicine Services, 41-46.
17. Ouellet D, Bockbrader HN, Wesche DL et al. (2001) Population pharmacokinetics of gabapentin in infants and children. Epilepsy Research, 47, 229-241.
18. Gatti G, Ferrari AR, Guerrini R et al. (2003) Plasma gabapentin concentrations in children with epilepsy: influence of age, relationship with dosage, and preliminary observations on correlation with clinical response. Ther Drug Monit, 25, 54-60.
19. Vollmer KO, Türck D, Wagner F, Jähnchen E, Anhut H, Thomann P (1989) Multiple dose pharmacokinetics of the new anticonvulsant gabapentin [Abstract]. Eur J Clin Pharmacol, 36(Suppl.), A310.
20. Türck D, Vollmer KO, Bockbrader H, Sedman A (1989) Dose-linerality of the new anticonvulsant gabapentin after multiple oral doses [Abstract]. Eur J Clin Pharmacol, 36(Suppl.), A310.